View Press Releases
-
Phenomix Sciences and InformedDNA Partner to Advance Genetics-Driven Obesity Care
Launching at HLTH 2024, the groundbreaking partnership offers payers, health systems, employers, and life science organizations access to personalized obesity care and treatment planning based on a patient’s DNA.
Oct 16, 2024
-
DNA Script Appoints Marc Montserrat as CEO to Drive Long-Term Commercial Growth for Groundbreaking Enzymatic DNA Synthesis Platform
DNA Script announces Marc Montserrat's appointment as CEO.
Oct 16, 2024
-
Firstsource positioned a ‘Leader’ in Everest Group's Healthcare Payer Business Process as a Service Solutions PEAK Matrix® Assessment 2024
-
Healthcasts Names Max Baumer Chief Operating Officer & Chief Financial Officer
Healthcasts, the leading online community for healthcare professional consultation and real-world experience, today announced the appointment of Max Baumer, CPA, as Chief Operating Officer and Chief Financial Officer. Baumer has spent over a decade overseeing finance and operations for companies experiencing exceptional growth including large hospital systems and healthcare staffing companies, making him uniquely positioned to bridge financial and operational duties in his role at Healthcasts.
Oct 15, 2024
-
90% of Hospital and Health System Revenue Cycle Leaders Believe GenAI Will Impact Medical Coding Operations
-
CAI Unveils Bold New Brand Identity at ISPE Annual Meeting & Expo
-
1upHealth Launches 1up Patient Connect Product Update to Enhance Patient Data Interoperability Across the Industry
-
Oxford University Hospitals NHS Foundation Trust Propels Digitisation with PhenoTips’ Genomic Health Record.
Oxford University Hospitals NHS Foundation Trust (OUH) accelerates their Digital by Default strategy by harnessing PhenoTips’ cloud-hosted Genomic Health Record to digitise, integrate, and standardise genomic care.
Sep 30, 2024
-
Sapio Sciences Enhances Bioanalysis LIMS and ELN with Advanced Immunogenicity Capabilities
Sapio Sciences, the science-aware™ lab informatics platform, today announced the addition of new immunogenicity bioanalysis features to its industry-leading lab informatics platform. These new capabilities in the Sapio LIMS (Laboratory Information Management System) and Sapio ELN (Electronic Lab Notebook) solutions streamline testing workflows for detecting anti-drug antibodies (ADA) and neutralizing antibodies (NAb).
Oct 14, 2024
-
PHARMASEAL AND LEDGER RUN FORGE PARTNERSHIP TO ENHANCE CLINICAL BUSINESS OPERATIONS
PHARMASEAL specializes in state-of-the-art trial management software for life sciences (unified CTMS/eTMF) and LEDGER RUN, INC., an innovative technology company focused on optimizing clinical operations in the areas of site budgeting, contracts and payments, announced their partnership today. Through the partnership, PHARMASEAL’S Engility® Platform software Engility CTMS, Engility eTMF and LEDGER RUN'S unique ClinRun™ platform will streamline and enhance clinical operation budgeting and payment processes with an intelligent approach and seamless integration.
Oct 2, 2024
-
Inizio Medical Appoints Matt Wadyka as President, US Medical Affairs
-
Exothera announced the appointment of Cedric Volanti as CEO
Exothera has announced the appointment of a new CEO, Cédric Volanti.
Oct 8, 2024
-
Laudio Insights Releases “Leader Inspired Work” to Empower Healthcare’s Critical Frontline Leaders
-
Pii Introduces Accelevate™ Early Development Platform, Enabling IND Submissions in 100 Days for Aseptic Products
New Platform Reduces IND Submission Timelines for Small and Mid-Sized Pharma Companies.
Oct 7, 2024
-
Synexa Life Sciences Expands Bioanalysis Capabilities with the Acquisition of CRO Alderley Analytical
Synexa Life Sciences, a specialist biomarker and bioanalysis service provider, announces the acquisition of Alderley Analytical Ltd, reflecting an important milestone in Synexa’s ‘buy and build’ growth strategy. By combining the two complementary companies, the group can now offer an even more comprehensive range of services to an enlarged customer base, both in large and small molecule drug development, and ranging from pre-clinical work to phase III clinical studies.
Oct 6, 2024
-
Phreesia and Ad Council Partnership Yields High Patient Engagement in 3 Mental Health Awareness Campaigns
-
Coronado Research announce engagement of Rob Nichols to support the growth of their Clinical Technology Practice
Coronado Research announced the engagement of Rob Nichols to support the build-out of its clinical technology practice and advise the executive leadership team as they deliver the broader company vision.
Oct 2, 2024
-
Certara Completes Acquisition of Chemaxon
The combined organization offers life sciences companies predictive biosimulation and scientific informatics capabilities, improving certainty in decision-making from discovery through commercialization.
Oct 1, 2024
-
CAI Appoints Sheena Dempsey as Chief Executive Officer
-
Proscia Launches Concentriq Embeddings and Developer Toolkit to Unleash Pathology AI Development
Proscia®, a global leader in AI-enabled pathology solutions for precision medicine, today announced the launch of Concentriq® Embeddings and the Proscia AI Toolkit, enabling life sciences organizations to accelerate the discovery and development of novel therapies and diagnostics.
Oct 2, 2024